Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Agilent Technologies™ XF RPMI Medium, pH 7.4

Catalog No. 103576100
Change view
Click to view available options
Quantity:
500 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
10-357-6100 500 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 10-357-6100 Supplier Agilent Technologies™ Supplier No. 103576100
Only null left
Add to Cart
Add to Cart

XF RPMI Medium, pH 7.4 contains 1 mM HEPES, with the pH of this medium being pre-adjusted to 7.4. It is validated for use with the Seahorse Real-Time ATP rate assay and the glycolytic rate assay.

  • RPMI-based specifically formulated for Agilent™ Seahorse XF assays to achieve optimal results
  • Contains no phenol red, bicarbonate, glucose, glutamine, or pyruvate, allowing for full customization
  • XF media with pH 7.4 is also available, simplifying the workflow, saving time for assay preparation, and ensuring consistent results across experiments
  • To ensure a proper final pH in assay media, Seahorse XF supplements must be used at recommended concentration range
  • Also recommended to use for all Seahorse XF assays

Specifications

Cell Line All
Cell Type All
Classification Animal Origin-free
Concentration 1X
Form Liquid
Product Type Seahorse XF Assay
Serum Level Serum-free
Sterility Sterile
With Additives None
Without Additives None
Quantity 500 mL
Formulation Liquid XF Medium Assay
pH 7.4
Culture Type Suspension Cell Culture
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.